In continuation of the prothrombotic cascade likely promoted by hyperhomocysteinemia and endothelial dysfunction related to the MTHFR C677T variant, the ACE I/D polymorphism may have added a further mechanistic layer to the patient’s vascular vulnerability. This evidence concerns the gene ACE and hyperhomocysteinemia.